
Boblim 0.2mg Tablet
Marketer
Zamixo Pharmaceuticals
Salt Composition
Voglibose (0.2mg)
Overview Boblim 0.2mg Tablet
Diabetol 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating post-prandial hyperglycemia (high blood sugar after meals). It's indicated when dietary modifications and other anti-diabetic agents prove insufficient in controlling elevated blood glucose. Diabetol 0.2mg should be administered immediately prior to meals. Dosage frequency is determined by your physician to optimize blood sugar control. Discontinue use only under medical supervision; abrupt cessation may elevate blood glucose, potentially leading to serious complications like renal impairment and vision loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetol 0.2mg alone doesn't typically cause hypoglycemia, concomitant use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose (table sugar) may be ineffective. Inform your physician of any pre-existing liver or kidney conditions before commencing treatment. Avoid use if you have bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should consult their doctor prior to use. Comprehensive disclosure of all medications currently being taken is crucial for safety. Limit alcohol consumption as it can elevate the hypoglycemia risk.
Primary Ingredients of Boblim 0.2mg Tablet
No text provided to rephrase.
Uses of Boblim 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Boblim 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Boblim tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Boblim 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Boblim 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Boblim 0.2mg Tablet should be taken on an empty stomach.
How Boblim 0.2mg Tablet works:
Glucodown 0.2mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Boblim 0.2mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
The medication Boblim 0.2mg Tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; yet, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Boblim 0.2mg Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Boblim 0.2mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Boblim 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.2mg Boblim tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Boblim 0.2mg Tablet :
Omit any missed Boblim 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Boblim 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Active Class | Alpha-glucosidase inhibitors |
